UNSPSC 51333004: Tepirindole

This classification denotes a dopamine antagonist with the molecular formula C16H19ClN2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X235XX30GK, chemically known as 5-chloro-3-(1,2,3,6-tetrahydro-1-propyl-4-pyridyl)indole but generally known as tepirindole, which bears US NIH Compound Identifier 68915. European Medicines Agency schedules Tepirindole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10904MIG.

UNSPSC 51333004 Tepirindole is a Commodity code that maps poorly to recent state and local procurement activity. The code nominally describes a specific pharmaceutical compound, yet the three most recent opportunities tagged to it involve naloxone (an opioid antagonist), generic multi-source pharmaceuticals and OTC products, and a pharmacy benefit program design initiative—none of which align with tepirindole's therapeutic scope. The mismatch suggests either inconsistent coding by issuing bodies or a data-entry error in the opportunity records. State and local health agencies, cooperative purchasing alliances, and health and human services commissions are the issuing bodies appearing in the recent record, but their actual procurements do not center on tepirindole.

The geographic spread of recent activity spans Florida, Texas, and Minnesota, with the most concrete solicitation posted by Seminole County, Florida (IFB 60459723LAS, due July 26, 2023) for naloxone and drug deactivation systems supplied quarterly; the Texas Health and Human Services Commission issued an RFI in April 2026 on direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) released an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products with proposals due March 26, 2026. The code shows little actionable recent activity directly relevant to tepirindole procurement itself, and business development professionals should verify code assignment before investing pursuit resources.